These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31640596)
61. The role of hepatitis C virus genotypes and core mutations in hepatocellular carcinoma in Cameroon. Amougou-Atsama M; Jean Adrien Atangana P; Noah Noah D; Fewou Moundipa P; Pineau P; Njouom R J Viral Hepat; 2020 Sep; 27(9):880-885. PubMed ID: 32301239 [TBL] [Abstract][Full Text] [Related]
62. Hepatitis C virus infection: Are there still specific problems with genotype 3? Gondeau C; Pageaux GP; Larrey D World J Gastroenterol; 2015 Nov; 21(42):12101-13. PubMed ID: 26576095 [TBL] [Abstract][Full Text] [Related]
63. Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital. Okushin K; Suzuki R; Tsutsumi T; Okamoto K; Ikeuchi K; Kado A; Minatsuki C; Minami-Kobayashi Y; Satoh N; Ikeda M; Harada S; Enooku K; Fujinaga H; Yotsuyanagi H; Koike K; Moriya K BMC Infect Dis; 2021 Apr; 21(1):399. PubMed ID: 33931015 [TBL] [Abstract][Full Text] [Related]
64. Highly Diverse Hepatitis C Strains Detected in Sub-Saharan Africa Have Unknown Susceptibility to Direct-Acting Antiviral Treatments. Davis C; Mgomella GS; da Silva Filipe A; Frost EH; Giroux G; Hughes J; Hogan C; Kaleebu P; Asiki G; McLauchlan J; Niebel M; Ocama P; Pomila C; Pybus OG; Pépin J; Simmonds P; Singer JB; Sreenu VB; Wekesa C; Young EH; Murphy DG; Sandhu M; Thomson EC Hepatology; 2019 Apr; 69(4):1426-1441. PubMed ID: 30387174 [TBL] [Abstract][Full Text] [Related]
65. Genotype 3 Infection: The Last Stand of Hepatitis C Virus. Chan A; Patel K; Naggie S Drugs; 2017 Feb; 77(2):131-144. PubMed ID: 28074358 [TBL] [Abstract][Full Text] [Related]
66. Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins. Li X; Li J; Feng Y; Cai H; Li YP; Peng T Antiviral Res; 2020 May; 177():104734. PubMed ID: 32057770 [TBL] [Abstract][Full Text] [Related]
67. Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress. Chida T; Watanabe S; Ohta K; Noritake H; Ito M; Suzuki T; Suda T; Kawata K Free Radic Biol Med; 2024 Feb; 212():199-206. PubMed ID: 38103659 [TBL] [Abstract][Full Text] [Related]
68. Clinical significance of hepatitis C virus genotypes. Zein NN Clin Microbiol Rev; 2000 Apr; 13(2):223-35. PubMed ID: 10755999 [TBL] [Abstract][Full Text] [Related]
69. Investigating the origin and spread of hepatitis C virus genotype 5a. Verbeeck J; Maes P; Lemey P; Pybus OG; Wollants E; Song E; Nevens F; Fevery J; Delport W; Van der Merwe S; Van Ranst M J Virol; 2006 May; 80(9):4220-6. PubMed ID: 16611881 [TBL] [Abstract][Full Text] [Related]
70. A comparative analysis of interferons and direct-acting antivirals on the expression of genes involved in hepatitis C pathogenesis. Farooq M; Rauf M; Tahir F; Manzoor S J Med Virol; 2021 Nov; 93(11):6241-6246. PubMed ID: 32706418 [TBL] [Abstract][Full Text] [Related]
71. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Scheel TK; Rice CM Nat Med; 2013 Jul; 19(7):837-49. PubMed ID: 23836234 [TBL] [Abstract][Full Text] [Related]
72. Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma. Hu Z; Muroyama R; Kowatari N; Chang J; Omata M; Kato N Cancer Sci; 2009 Dec; 100(12):2465-8. PubMed ID: 20175782 [TBL] [Abstract][Full Text] [Related]
73. Global hepatitis C elimination: history, evolution, revolutionary changes and barriers to overcome. Oancea CN; Butaru AE; Streba CT; Pirici D; Rogoveanu I; Diculescu MM; Gheonea DI Rom J Morphol Embryol; 2020; 61(3):643-653. PubMed ID: 33817705 [TBL] [Abstract][Full Text] [Related]
74. Worldwide prevalence, genotype distribution and management of hepatitis C. Guntipalli P; Pakala R; Kumari Gara S; Ahmed F; Bhatnagar A; Endaya Coronel MK; Razzack AA; Solimando AG; Thompson A; Andrews K; Enebong Nya G; Ahmad S; Ranaldo R; Cozzolongo R; Shahini E Acta Gastroenterol Belg; 2021; 84(4):637-656. PubMed ID: 34965046 [TBL] [Abstract][Full Text] [Related]
75. New Antiviral Agents for Treatment of Hepatitis C. Egerman RS Clin Obstet Gynecol; 2019 Dec; 62(4):823-834. PubMed ID: 31094712 [TBL] [Abstract][Full Text] [Related]
76. After the Storm: Persistent Molecular Alterations Following HCV Cure. Seurre C; Roca Suarez AA; Testoni B; Zoulim F; Grigorov B Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000179 [TBL] [Abstract][Full Text] [Related]
77. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study. Yu ML; Tsai WL; Chu CJ; Kao JH Kaohsiung J Med Sci; 2021 Mar; 37(3):245-252. PubMed ID: 33089964 [TBL] [Abstract][Full Text] [Related]